News & Updates
Filter by Specialty:
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022
Do outpatient ophthalmologic procedures increase risk for acute MI?
Ophthalmologic procedures performed in an outpatient setting do not seem to heighten the risk for acute myocardial infarction (AMI), a study has shown.
Do outpatient ophthalmologic procedures increase risk for acute MI?
29 Mar 2022
Low BP ups risk of open-angle glaucoma
Low levels of blood pressure (BP) appear to elevate the risk of developing open-angle glaucoma (OAG), reveals a recent US study. In addition, there is no evidence supporting a differential effect of medically treated and untreated low BP.
Low BP ups risk of open-angle glaucoma
19 Mar 2022
HDL3 cholesterol tied to primary open-angle glaucoma
A causal and specific association exists between high-density lipoprotein (HDL) 3 cholesterol and primary open-angle glaucoma (POAG), suggests a cross-sectional study, noting that dysregulation of cholesterol transport may contribute to the pathogenesis of POAG.
HDL3 cholesterol tied to primary open-angle glaucoma
18 Mar 2022
Lower resilience tied to poorer medication adherence in glaucoma patients
The COVID-19 pandemic has worsened the adherence to ocular hypotensive medication among patients with primary open-angle glaucoma (POAG), according to a study. Such reduction is potentially driven by lower psychometric measures of resilience and more confrontational coping strategies.